Further Information
FGFR2 , fibroblast growth factor receptor 2, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, FLJ98662, JWS, K-SAM, KGFR, TK14, TK25, BEK fibroblast growth factor receptor, FGF receptor, FGFR-2, bacteria-expressed kinase, hydroxyaryl-protein kinase, keratinocyte growth factor receptor, protein tyrosine kinase, receptor like 14, soluble FGFR4 variant 4
Peptide ELISA: antibody detection limit dilution 1:64000.Western Blot:Approx 100kDa band observed in Human lysates of cell line A549 (calculated MW of 92.0kDa according to NP_000132.1 and of 92.1kDa according to NP_075259.2). Recommended concentration: 0.3-1ug/ml.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Mouse, Rat, Dog, Pig, Cow
The immunogen for this antibody is: C-GREKEITASPDY
2263
fibroblast growth factor receptor 2
FGFR2
Homo sapiens
Liquid
NP_000132.3, NP_075259.4, NP_001138385.1, NP_001138386.1, NP_001138387.1, NP_001138388.1, NP_001138390.1, NP_001138391.1
221316639
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
This antibody is expected to recognise all reported isoforms except isoform 7 (NP_001138389.1). The immunizing peptide represents part of the extracellular domain.
P21802